Compared side by side
Kisspeptin-10 vs gonadorelin: how they differ
The short answer
They work one step apart on the same hormone chain: kisspeptin-10 stimulates the release of GnRH, and gonadorelin is synthetic GnRH itself, which signals the pituitary to release LH and FSH. Kisspeptin-10 relies on your own GnRH neurons still working, while gonadorelin acts directly at the pituitary. Gonadorelin is mostly run alongside TRT 2–3 times a week with the aim of keeping testicular function, a use no published trial has tested, and kisspeptin-10 is research-stage, with fertility trials recruiting.
Side by side
| Compared | Kisspeptin-10 | Gonadorelin |
|---|---|---|
| Category | Sexual health | Sexual health |
| Also known as | KP-10, Kisspeptin, Metastin fragment | GnRH, Gonadotropin-releasing hormone, Gonadorelin acetate |
| What it is | A hypothalamic neuropeptide that sits upstream of GnRH in your hormonal cascade — it's the signal that tells your brain to start producing reproductive hormones. | A synthetic version of the hormone your hypothalamus uses to signal your pituitary to release LH and FSH — the hormones that drive testosterone production and fertility. |
| How it works | Hypothalamic neuropeptide that stimulates GnRH release, driving LH and FSH production. Key regulator of the HPG (hypothalamic-pituitary-gonadal) axis. Phase 2 trials in hypogonadism and hypothalamic amenorrhea are recruiting. In men, LH rises within 30–60 minutes of a dose, with testosterone following over hours. | Synthetic GnRH (identical to the natural hormone) that stimulates pituitary release of LH and FSH. Used alongside TRT with the aim of maintaining testicular function, testosterone production and fertility; that use hasn't been tested in trials. Continuous exposure (an infusion or long-acting GnRH drugs) shuts the axis down, while intermittent injections of short-lived gonadorelin stimulate it; 2–3x weekly is the common clinic schedule. |
| Commonly reported | A libido or mood lift within hours of a dose for some, while many find the effects subtle or short-lived. | Some users on TRT say it helps keep testicular size and fullness compared with TRT alone, and many describe it as weaker than hCG. It's usually injected 2–3 times a week; what shuts the system down is constant exposure (like a drip or long-acting GnRH drugs), not daily use. |
| Studied range | Research range: 50–500 mcg. Studied in research — not a recommendation. | Research range: 100 mcg. Studied in research — not a recommendation. |
| How often | Pulsatile — 2–3x/week | 2–3x weekly (pulsatile) |
| Half-life | ~4 min (kisspeptin-54, a longer form, lasts ~28 min) | ~2–10 min |
| Route | SubQ injection | SubQ injection |
| Typical run | Pulsatile 2–3x/week. Limited long-term community data. Used in defined cycles. | Used continuously alongside TRT with the aim of maintaining testicular function, typically 2–3x/week ongoing. |
| Evidence | Emerging: primarily preclinical / limited human data | Established: clinical trials or FDA-approved use exists |
| Common side effects | Limited human data, LH/testosterone surge after dosing, potential mood effects, injection site reaction | Generally well tolerated, injection site reactions, headache |
- Category
- Kisspeptin-10Sexual health
- GonadorelinSexual health
- Also known as
- Kisspeptin-10KP-10, Kisspeptin, Metastin fragment
- GonadorelinGnRH, Gonadotropin-releasing hormone, Gonadorelin acetate
- What it is
- Kisspeptin-10A hypothalamic neuropeptide that sits upstream of GnRH in your hormonal cascade — it's the signal that tells your brain to start producing reproductive hormones.
- GonadorelinA synthetic version of the hormone your hypothalamus uses to signal your pituitary to release LH and FSH — the hormones that drive testosterone production and fertility.
- How it works
- Kisspeptin-10Hypothalamic neuropeptide that stimulates GnRH release, driving LH and FSH production. Key regulator of the HPG (hypothalamic-pituitary-gonadal) axis. Phase 2 trials in hypogonadism and hypothalamic amenorrhea are recruiting. In men, LH rises within 30–60 minutes of a dose, with testosterone following over hours.
- GonadorelinSynthetic GnRH (identical to the natural hormone) that stimulates pituitary release of LH and FSH. Used alongside TRT with the aim of maintaining testicular function, testosterone production and fertility; that use hasn't been tested in trials. Continuous exposure (an infusion or long-acting GnRH drugs) shuts the axis down, while intermittent injections of short-lived gonadorelin stimulate it; 2–3x weekly is the common clinic schedule.
- Commonly reported
- Kisspeptin-10A libido or mood lift within hours of a dose for some, while many find the effects subtle or short-lived.
- GonadorelinSome users on TRT say it helps keep testicular size and fullness compared with TRT alone, and many describe it as weaker than hCG. It's usually injected 2–3 times a week; what shuts the system down is constant exposure (like a drip or long-acting GnRH drugs), not daily use.
- Studied range
- Kisspeptin-10Research range: 50–500 mcg. Studied in research — not a recommendation.
- GonadorelinResearch range: 100 mcg. Studied in research — not a recommendation.
- How often
- Kisspeptin-10Pulsatile — 2–3x/week
- Gonadorelin2–3x weekly (pulsatile)
- Half-life
- Kisspeptin-10~4 min (kisspeptin-54, a longer form, lasts ~28 min)
- Gonadorelin~2–10 min
- Route
- Kisspeptin-10SubQ injection
- GonadorelinSubQ injection
- Typical run
- Kisspeptin-10Pulsatile 2–3x/week. Limited long-term community data. Used in defined cycles.
- GonadorelinUsed continuously alongside TRT with the aim of maintaining testicular function, typically 2–3x/week ongoing.
- Evidence
- Kisspeptin-10Emerging: primarily preclinical / limited human data
- GonadorelinEstablished: clinical trials or FDA-approved use exists
- Common side effects
- Kisspeptin-10Limited human data, LH/testosterone surge after dosing, potential mood effects, injection site reaction
- GonadorelinGenerally well tolerated, injection site reactions, headache
Typical run: Community practice — opinions vary. Not a clinical recommendation.

Week by week
Each entry’s cards by day window, as the compound pages show them. Day 1 is the day you start it.
Kisspeptin-10
- Day 1–7 Fast LH and testosterone surge
- Day 7–28 HPG axis coming online
- Day 28–84 Assess labs, decide next step
Gonadorelin
- Day 1–14 Settling into the cadence
- Day 14–84 Testicular function holding
- Day 84–365 Long-term maintenance pattern
Together or one or the other
Kisspeptin-10 and gonadorelin are a common stack: Kisspeptin-10 lists gonadorelin among its common stacks.
Questions people ask
How long do Kisspeptin-10 and gonadorelin last?
The half-life of Kisspeptin-10 is ~4 min (kisspeptin-54, a longer form, lasts ~28 min). The half-life of gonadorelin is ~2–10 min.
How often are Kisspeptin-10 and gonadorelin taken?
Kisspeptin-10: pulsatile — 2–3x/week. Route: SubQ injection. Gonadorelin: 2–3x weekly (pulsatile). Route: SubQ injection.
How are Kisspeptin-10 and gonadorelin dosed in research?
The research range for Kisspeptin-10 is 50–500 mcg. The research range for gonadorelin is 100 mcg. Studied in research — not a recommendation.
What are the common side effects of Kisspeptin-10 and gonadorelin?
For Kisspeptin-10, the library lists: limited human data, LH/testosterone surge after dosing, potential mood effects, injection site reaction. For gonadorelin: generally well tolerated, injection site reactions, headache.
Are Kisspeptin-10 and gonadorelin taken together?
Kisspeptin-10 and gonadorelin are a common stack: Kisspeptin-10 lists gonadorelin among its common stacks.